The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'March, 2019'. If you still can't find what you are looking for, try using the search box.
(Los Angeles, CA and Glasgow U.K. – March 28, 2019) HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, and Tissue Solutions Ltd, a leading global provider of diseased human biosamples for research, today announced their partnership to supply customers with an expanded selection of well-qualified disease-state biomaterials in fresh, frozen, and FFPE formats.
Read the rest of entry »
Entrust Resource Solutions has launched an aggressive 5-year growth and acquisition strategy that will benefit our global customer base by enabling them to hire top talent while achieving the business growth necessary to reach our targeted £10 million turnover.
AMSBIO offers an unmatched portfolio of over 2000 tissue microarrays (TMAs), one of the best sample formats for rapid detection of cellular localization of RNA and protein expression.
Diamond Pharma Services has provided EU regulatory support to Akcea since 2016, resulting in a positive CHMP opinion for the grant of a Conditional Marketing Authorisation for WAYLIVRA .
OXFORD, England, March 22, 2019 /PRNewswire/ -- Evox Therapeutics Ltd ('Evox' or the 'Company'), a leading exosome therapeutics company, today announces that it has secured £1.5 million in funding from Innovate UK, the UK's Innovation Agency, through the Biomedical Catalyst Early Stage Award.
Arecor Limited, the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, today announces that a Phase I Clinical Trial Application (“CTA”) for product candidate AT247 has been approved by the Bundesamt für Sicherheit im Gesundheitswesen (BASG), the Austrian Federal Office for Safety in Health Care.
AMSBIO has added a new range of GCaMP calcium indicators (jGCaMP7b, jGCaMP7c, jGCaMP7f, jGCaMP7s) to their portfolio of ready-to-use adeno-associated virus (AAV) biosensor products. These viruses encoded biosensors are supplied ready for use for neural activity studies in vivo.
At a black-tie dinner held in Edinburgh on Thursday 28th February 2019, more than 700 luminaries came together at the Scotland's Life Sciences Dinner & Annual Awards to celebrate their collective achievements of 2018. A year which saw international expansion, infrastructure improvements and a record £85 million of equity investment.
N-site is a unique knowledge portal for life sciences companies containing guidance on tax, legal and IP specialisms. This resource is now free to sign up and use for all registering companies. New guidance notes have also been added along with a suite of workshops. See N-Site.co.uk for further details.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.